Rank Radar Watchlist Portfolio My

SINWOOX.COM© 2025 SINWOOX

투자 조언이 아닌 정보 제공 서비스입니다. 모든 투자 결정의 책임은 투자자 본인에게 있습니다.

Rank
Radar
Portfolio
Watch
My

ALNY rebound signal — SINWOOX

ALNY

US

Alnylam Pharmaceuticals, Inc.

$291.48-0.19%

Weak / no signal

Score28

1D-0.19%

5D-3.22%

20D-12.57%

Vol0.8×

Rank#24

Universe#86

Price · 20 sessions

$291.48-17.15%

Simplified

Signal status

Weak / no signal28

Recovery score sits below our moderate band — fewer aligned factors.

OversoldHigh Volatility

Score breakdown · 20D

Drawdown depth

30

×0.30

Volume vs avg

0

×0.22

Rebound off low

23

×0.28

1D momentum

23

×0.08

vs Market—×0.12

ALNYAlnylam Pharmaceuticals, Inc.$291.48

06:47 AM · 4 minutes agoUpdated 06:47 AM (New York, ET) · 4 minutes ago

Source: yahoo-finance

Current market state

1D

-0.19%

5D

-3.22%

20D change

-12.57%

Volume ratio

0.8×

Category rank

#24

stock

Universe rank

#86

Drop strength

12.6% / 20d

Volume vs avg

0.8×

Rebound signal

Early

Signal History

Date	Score	Tier	Rank
2026-05-12	16	Weak	#46

News

Stock TitanMay 12, 06:33 AM

Heart drug vutrisiran tied to fewer deaths in ATTR-CM patients

Heart drug vutrisiran tied to fewer deaths in ATTR-CM patients Stock Titan

ChartMillMay 8, 07:00 AM

ALNY Stock Price, Quote & Chart | ALNYLAM PHARMACEUTICALS INC (NASDAQ:ALNY)

ALNY Stock Price, Quote & Chart | ALNYLAM PHARMACEUTICALS INC (NASDAQ:ALNY) ChartMill

Stock TitanMay 7, 12:04 PM

Alnylam will stream two healthcare conference presentations in May and June

Alnylam will stream two healthcare conference presentations in May and June Stock Titan

Quiver QuantitativeApr 30, 07:00 AM

ALNYLAM PHARMACEUTICALS ($ALNY) Releases Q1 2026 Earnings

ALNYLAM PHARMACEUTICALS ($ALNY) Releases Q1 2026 Earnings Quiver Quantitative

DirectorsTalk InterviewsApr 27, 07:00 AM

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Unpacking the 46.95% Potential Upside for Investors

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Unpacking the 46.95% Potential Upside for Investors DirectorsTalk Interviews

Seeking AlphaApr 23, 07:00 AM

Alnylam Pharmaceuticals: Cutting-Edge Pharma Stock Still Feels A Little Overvalued (ALNY)

Alnylam Pharmaceuticals: Cutting-Edge Pharma Stock Still Feels A Little Overvalued (ALNY) Seeking Alpha

Quiver QuantitativeApr 16, 07:00 AM

Alnylam (ALNY) slides 4% as valuation concerns linger after recent analyst reset

Alnylam (ALNY) slides 4% as valuation concerns linger after recent analyst reset Quiver Quantitative

Stock TitanApr 16, 07:00 AM

Alnylam to post Q1 results before market open, webcast at 8:30 ET

Alnylam to post Q1 results before market open, webcast at 8:30 ET Stock Titan

Quiver QuantitativeMar 25, 07:00 AM

Alnylam (ALNY) jumps 6.7% as investors refocus on TTR franchise after company webinar | ALNY Stock News

Alnylam (ALNY) jumps 6.7% as investors refocus on TTR franchise after company webinar | ALNY Stock News Quiver Quantitative

ForbesMar 11, 07:00 AM

How Alnylam Stock Weathers Market Shocks

How Alnylam Stock Weathers Market Shocks Forbes

Yahoo FinanceFeb 28, 08:00 AM

Canaccord Genuity Maintains Buy Rating on Alnylam Pharmaceuticals, Inc. (ALNY) Stock

Canaccord Genuity Maintains Buy Rating on Alnylam Pharmaceuticals, Inc. (ALNY) Stock Yahoo Finance

TIKR.comFeb 8, 08:00 AM

Down 34% From All-Time Highs, Can Alnylam Pharmaceuticals Stock Finally Recover In 2026?

Down 34% From All-Time Highs, Can Alnylam Pharmaceuticals Stock Finally Recover In 2026? TIKR.com